This approach is grounded in scientific evidence from multiple fields, including clinical trials and real-world data on adherence, the behavioral psychology of habit formation, present bias, and outcomes research on comprehensive obesity care
Lactobacillus reuteri has been utilized clinically to treat gastrointestinal disorders, such as irritable complaints, diarrhea, and constipation (Peng et al
What are GLP-1 patches and what do they actually contain
Market Drivers : Growth is driven by the rising prevalence of obesity and Type 2 diabetes, the shift toward incretin-based therapies, expanding clinical evidence of weight-loss benefits, and improved patient awareness, supported by physician advocacy and digital health engagement